The Nov. 28 Red Hot Hockey game at Madison Square Garden featured an on-ice appearance by Cornell President Elizabeth Garrett, an Olympic medalist and a marriage proposal before ending in a 3-3 tie.
An experimental chemotherapy kills leukemia cells that are abundant in proteins critical to cancer growth, according to new research from Weill Cornell Medicine.
Architecture students studying in New York City and preparing for job searches received one-on-one feedback on their portfolios from practicing architects, including several alumni.
A discovery by Weill Cornell Medicine investigators may settle a longstanding debate about how cancers spread, the investigators say, and may change the way many forms of the disease are treated.
Weill Cornell Medicine has entered into an agreement with Top Spring Huaxia Medical Investment to help it develop a modern outpatient diagnostic clinic in Shenzhen, China.
New Cornell research published online Nov. 9 in Nature Cell Biology describes a system that controls levels of a cell's sensors, which are responsible for detecting the accumulation of misfolded proteins.
Cornell biomedical engineers have developed specialized white blood cells – dubbed "super natural killer cells" – that seek out cancer cells in lymph nodes with only one purpose: destroy them.
At the Cornell Entrepreneurship Summit in New York City Nov. 6, CEOs presented, students pitched business ideas, and President Garrett and spoke of Cornell's entrepreneurial roots.
